◆英語タイトル:New England Biolabs Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011382
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月22日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
New England Biolabs Inc (NEB) is a life science company that develops recombinant and native enzymes for genomic research. The company offers products such as competent cells, DNA plasmids, protein tools, buffers and strains, and others. It has applications in cloning and synthetic biology, RNA analysis, DNA amplification and PCR, DNA modification, library preparation for next generation sequencing and epigenetic, among others. It also provides interactive tools for research and experimental designs. The company has its presence with subsidiaries in Canada, China, France, Germany, Japan, Singapore and the UK. It offers its products globally through a channel of network distributors. NEB is headquartered in Ipswich, Massachusetts, the US.
New England Biolabs Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
New England Biolabs Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
New England Biolabs Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
New England Biolabs Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
New England Biolabs Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
New England Biolabs Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
New England Biolabs Inc, Medical Equipment, Deal Details 10
Partnerships 10
New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology 10
New England Biolabs Enters into Agreement with CasZyme 11
New England Biolabs and TTP Enters into Partnership 12
New England Biolabs Enters Into Co-Development Agreement With Hamilton Robotics 13
New England Biolabs Enters Into Co-Marketing Agreement With Rubicon Genomics 14
New England Biolabs Enters Into Licensing Agreement With Sequenom 15
New England Biolabs Inc – Key Competitors 16
New England Biolabs Inc – Key Employees 17
New England Biolabs Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Strategy And Business Planning 20
Jul 25, 2017: New England Biolabs joins EMBL’s Corporate Partnership Programme 20
Product News 21
May 30, 2017: New England Biolabs Launches New NEBNext Ultra II RNA Kits for Streamlined NGS Library Preparation with as Little as 5 ng of Total RNA 21
Dec 09, 2016: New England Biolabs Lights The Way With Luna Universal Kits For Simplified qPCR and RT-qPCR 22
Other Significant Developments 23
Oct 27, 2016: New England Biolabs Announces Agreement with AmpTec GmbH to supply key mRNA Synthesis Reagents 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List of Tables
New England Biolabs Inc, Medical Equipment, Key Facts 2
New England Biolabs Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
New England Biolabs Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
New England Biolabs Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
New England Biolabs Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
New England Biolabs Inc, Deals By Market, 2011 to YTD 2017 8
New England Biolabs Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology 10
New England Biolabs Enters into Agreement with CasZyme 11
New England Biolabs and TTP Enters into Partnership 12
New England Biolabs Enters Into Co-Development Agreement With Hamilton Robotics 13
New England Biolabs Enters Into Co-Marketing Agreement With Rubicon Genomics 14
New England Biolabs Enters Into Licensing Agreement With Sequenom 15
New England Biolabs Inc, Key Competitors 16
New England Biolabs Inc, Key Employees 17
New England Biolabs Inc, Subsidiaries 18